Abstract
There is a substantial need for an accessible suite of cognitive measures to assess and monitor signs of chemotherapy-related cognitive impairment during the treatment and survivorship phases of the cancer control continuum. To address this need we designed and demonstrated a Cognitive Assessment and Monitoring Platform for Integrative Research (CAMPFIRE), a privacy-compliant software system to support the administration of cognitive assessment measures and facilitate secure provider-patient interaction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Cancer Society: Cancer Facts & Figures 2016. American Cancer Society, Atlanta (2016)
American Cancer Society: Cancer Treatment and Survivorship Facts & Figures 2014–2015. American Cancer Society, Atlanta (2014)
Ahles, T.A., Root, J.C., Ryan, E.L.: Cancer - and cancer treatment-associated cognitive change: an update on the state of the science. J. Clin. Oncol. 30(30), 3675–3686 (2012). https://doi.org/10.1200/JCO.2012.43.0116
Ono, M., Ogilvie, J.M., Wilson, J.S., Green, H.J., Chambers, S.K., Ownsworth, T., Shum, D.H.K.: A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer. Neuro-Oncology 5, 59 (2015). https://doi.org/10.3389/fonc.2015.00059
Wefel, J.S., Schagen, S.B.: Chemotherapy-related cognitive dysfunction. Curr. Neurol. Neurosci. Rep. 12(3), 267–275 (2012). https://doi.org/10.1007/s11910-012-0264-9
Ahles, T.A., Saykin, A.J., Furstenberg, C.T., Cole, B., Mott, L.A., Skalla, K., Whedon, M.B., Bivens, S., Mitchell, T., Greenberg, E.R., Silberfarb, P.M.: Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J. Clin. Oncol. Official J. Am. Soc. Clin. Oncol. 20(2), 485–493 (2002)
Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., Verma, S.: Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology 18(2), 134–143 (2009). https://doi.org/10.1002/pon.1379
Yamada, T.H., Denburg, N.L., Beglinger, L.J., Schultz, S.K.: Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. J. Neuropsychiatry Clin. Neurosci. 22(1), 48–54 (2010). https://doi.org/10.1176/appi.neuropsych.22.1.48
Wefel, J.S., Saleeba, A.K., Buzdar, A.U., Meyers, C.A.: Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116(14), 3348–3356 (2010). https://doi.org/10.1002/cncr.25098
Wefel, J.S., Kesler, S.R., Noll, K.R., Schagen, S.B.: Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J. Clin. 65(2), 123–138 (2015). https://doi.org/10.3322/caac.21258
Janelsins, M.C., Kesler, S.R., Ahles, T.A., Morrow, G.R.: Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int. Rev. Psychiatry 26(1), 102–113 (2014). http://doi.org/10.3109/09540261.2013.864260
Jean-Pierre, P., Johnson-Greene, D., Burish, T.G.: Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development. Support. Care Cancer 22(8), 2251–2260 (2014). https://doi.org/10.1007/s00520-014-2162-y
Hutchinson, A.D., Hosking, J.R., Kichenadasse, G., Mattiske, J.K., Wilson, C.: Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat. Rev. 38(7), 926–934 (2012). https://doi.org/10.1016/j.ctrv.2012.05.002
Lai, J.-S., Wagner, L.I., Jacobsen, P.B., Cella, D.: Self-reported cognitive concerns and abilities: two sides of one coin? Psycho-Oncology 23(10), 1133–1141 (2014). https://doi.org/10.1002/pon.3522
Wefel, J.S., Vardy, J., Ahles, T., Schagen, S.B.: International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 12(7), 703–708 (2011). https://doi.org/10.1016/S1470-2045(10)70294-1
Jansen, C.E., Cooper, B.A., Dodd, M.J., Miaskowski, C.A.: A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support. Care Cancer 19(10), 1647–1656 (2011). https://doi.org/10.1007/s00520-010-0997-4
Kaiser, J., Bledowski, C., Dietrich, J.: Neural correlates of chemotherapy-related cognitive impairment. Cortex 54, 33–50 (2014). https://doi.org/10.1016/j.cortex.2014.01.010
van Dam, F.S., Schagen, S.B., Muller, M.J., Boogerd, W., Droogleever Fortuyn, M.E., Rodenhuis, S.: Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J. Natl. Cancer Inst. 90(3), 210–218 (1998)
Wieneke, M.H., Dienst, E.R.: Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 4(1), 61–66 (1995). https://doi.org/10.1002/pon.2960040108
Schagen, S.B., Boogerd, W., Muller, M.J., Huinink, W.T.B., Moonen, L., Meinhardt, W., Van Dam, F.S.: Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer (2008)
Skaali, T., Fosså, S.D., Andersson, S., Cvancarova, M., Langberg, C.W., Lehne, G., Dahl, A.A.: Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress. J. Psychosom. Res. 70(5), 403–410 (2011). https://doi.org/10.1016/j.jpsychores.2010.12.004
Weintraub, S., Dikmen, S.S., Heaton, R.K., Tulsky, D.S., Zelazo, P.D., Bauer, P.J., Carlozzi, N.E., Slotkin, J., Blitz, D., Wallner-Allen, K., Fox, N.A., Beaumont, J.L., Mungas, D., Nowinski, C.J., Richler, J., Deocampo, J.A., Anderson, J.E., Manly, J.J., Borosh, B., Havlik, R., Conway, K., Edwards, E., Freund, L., King, J.W., Moy, C., Witt, E., Gershon, R.C.: Cognition assessment using the NIH toolbox. Neurology, 80(11 Suppl 3), S54–S64 (2013). http://doi.org/10.1212/WNL.0b013e3182872ded
Weintraub, S., Dikmen, S.S., Heaton, R.K., Tulsky, D.S., Zelazo, P.D., Slotkin, J.6., Carlozzi, N.E., Bauer, P.J., Wallner-Allen, K., Fox, N., Havlik, R., Beaumont, J.L., Mungas, D., Manly, J.J., Moy, C., Conway, K., Edwards, E., Nowinski, C.J., Gershon, R.: The cognition battery of the NIH toolbox for assessment of neurological and behavioral function: validation in an adult sample. J. Int. Neuropsychol. Soc. JINS 20(6), 567–578 (2014). https://doi.org/10.1017/S1355617714000320
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., Cook, K., DeVellis, R., DeWalt, D., Fries, J.F., Gershon, R., Hahn, E.A., Lai, J.-S., Pilkonis, P, Revicki, D., Rose, M., Weinfurt, K., Hays, R.: Initial adult health item banks and first wave testing of the patient-reported outcomes measurement information system (PROMISTM) network: 2005–2008. J. Clin. Epidemiol. 63(11), 1179–1194 (2010). https://doi.org/10.1016/j.jclinepi.2010.04.011
Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J.F., Bruce, B., Rose, M.: The patient-reported outcomes measurement information system (PROMIS). Med. Care 45(5 Suppl 1), S3–S11 (2007). http://doi.org/10.1097/01.mlr.0000258615.42478.55
Riley, W.T., Rothrock, N., Bruce, B., Christodolou, C., Cook, K., Hahn, E.A., Cella, D.: Patient-reported outcomes measurement information system (PROMIS) domain names and definitions revisions: further evaluation of content validity in IRT-derived item banks. Qual. Life Res. Int. J. Qual. Life Aspects Treat. Care Rehabil. 19(9), 1311–1321 (2010). https://doi.org/10.1007/s11136-010-9694-5
Cella, D., Lai, J.-S., Nowinski, C.J., Victorson, D., Peterman, A., Miller, D., Bethoux, F., Heinemann, A., Rubin, S., Cavazos, J.E., Reder, A.T., Sufit, R., Simuni, T., Holmes, G.L., Siderowf, A., Wojna, V., Bode, R., McKinney, N., Podrabsky, T., Wortman, K., Choi, S., Gershon, R., Rothrock, N., Moy, C.: Neuro-QOL brief measures of health-related quality of life for clinical research in neurology. Neurology 78(23), 1860–1867 (2012). http://doi.org/10.1212/WNL.0b013e318258f744
O’Farrell, E., MacKenzie, J., Collins, B.: Clearing the Air: a review of our current understanding of “chemo fog”. Current Oncol. Rep. 15(3), 260–269 (2013). https://doi.org/10.1007/s11912-013-0307-7
Parsey, C.M., Schmitter-Edgecombe, M.: Applications of technology in neuropsychological assessment. Clin. Neuropsychol. 27(8) (2013). http://doi.org/10.1080/13854046.2013.834971
Zhang, L., Chai, X., Ling, S., Fan, J., Yang, K., Ren, Q.: Dispersion and accuracy of simulated phosphene positioning using tactile board. Artif. Organs 33(12), 1109–1116 (2009). https://doi.org/10.1111/j.1525-1594.2009.00826.x
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this paper
Cite this paper
Jacobs, P., Anello, D., Elkin-Frankston, S. (2019). Using Design to Connect Patients, Providers, and Researchers: A Cognitive Assessment and Monitoring Platform for Integrative Research (CAMPFIRE). In: Lightner, N. (eds) Advances in Human Factors and Ergonomics in Healthcare and Medical Devices. AHFE 2018. Advances in Intelligent Systems and Computing, vol 779. Springer, Cham. https://doi.org/10.1007/978-3-319-94373-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-94373-2_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-94372-5
Online ISBN: 978-3-319-94373-2
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)